Dendritic Polyethylene Glycol Derivative for Drug Solubility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current dendrimers face issues such as toxicity due to high N atom content, biodegradability problems with aromatic rings, and hydrophobic properties that limit their compatibility with hydrophilic and strongly polar drugs, hindering their application in biomedical and pharmaceutical fields.
Innovation Solution
A dendritic polyethylene glycol derivative with a branched structure and multiple end functional groups is developed, offering improved water solubility, biocompatibility, and low toxicity, allowing for enhanced drug loading and bioavailability, and is synthesized using a convergent method that includes nucleophilic substitution and amidation reactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If polyamidoamine dendrimers are used to provide high drug loading capacity, then the dendrimer contains a large amount of N atoms which form cations that interact with anions on cell membranes, causing toxicity
Solution Approach 1:
The patent changes the chemical composition parameters by replacing N-containing polyamidoamine units with polyethylene glycol (PEG) units. This parameter change eliminates the cationic charge that causes toxicity while maintaining the dendrimer structure and drug loading capacity through the hydrophilic PEG chains.
Solution Approach 2:
The patent creates a composite dendrimer structure combining polyethylene glycol units with appropriate linkers and terminal groups. This composite approach maintains the functional properties of dendrimers (high drug loading, controlled release) while using biocompatible PEG material to eliminate toxicity.
2Productivity
If glutamic acid-alanine dipeptide dendrimers are synthesized to achieve high generation numbers, then the dendrimer carries more aromatic rings that are difficult to degrade, resulting in long retention time in the organism
Solution Approach 1:
The patent changes the material composition from aromatic-containing dipeptide units to aliphatic polyethylene glycol units. This parameter change eliminates aromatic rings from the dendrimer structure, enabling rapid biodegradation through hydrolysis of the PEG chains while maintaining high synthesis efficiency through convergent synthesis methods.
3Adaptability or versatility
If existing dendrimers are used to provide hydrophobic properties, then they can load hydrophobic drugs, but they exhibit poor compatibility with hydrophilic and strongly polar drugs
Solution Approach 1:
The patent changes the surface properties of the dendrimer by using hydrophilic polyethylene glycol units instead of hydrophobic aromatic units. This parameter change makes the dendrimer surface hydrophilic, enabling compatibility with both hydrophobic and hydrophilic drugs through appropriate functional group selection at the terminal positions.
Solution Approach 2:
The patent creates a universal dendrimer platform using polyethylene glycol that can accommodate various types of drugs (hydrophilic, hydrophobic, polar, non-polar) by selecting appropriate terminal functional groups. This multi-functional approach eliminates the need for separate dendrimer designs for different drug types.
4Quantity of substance
If polyethylene glycol is used to modify drugs to improve water solubility, then the drug becomes more soluble, but the internal hydrophobic space of the dendrimer is not utilized and wrapping and loading functions are wasted
Solution Approach 1:
The patent implements a nested structure where the polyethylene glycol chains are arranged in a dendritic configuration with terminal functional groups that can wrap around and load hydrophobic drugs within the dendrimer structure. This nesting approach utilizes both the hydrophilic PEG exterior for solubility and the internal structure for drug wrapping and loading.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The dendritic polyethylene glycol derivative effectively improves the solubility and bioavailability of insoluble drugs, addressing the limitations of existing dendrimers by providing a biocompatible and efficient carrier for drug modification, with mild reaction conditions and industrial scalability.
Implementation Method 1
A majority of the existing dendrimers exhibit a hydrophobic property, which limits the dendrimers to be jointly applied with a large number of hydrophilic and strongly polar drugs; although a grafting problem can be solved by surface modification of polyethylene glycol
Implementation Method 2
the dendritic polyethylene glycol derivative has good water solubility and biocompatibility and very low toxicity, and can be used as a carrier to modify an insoluble drug to improve the water solubility of the drug
Data Source
AI summary
The disclosure discloses a dendritic polyethylene glycol derivative and a preparation method and an application thereof. The dendritic polyethylene glycol derivative has a structure of formula (I), has multiple end functional groups, has a stronger water solubility in comparison with linear-chain polyethylene glycol, and can solve a problem of insufficient water solubility due to the increase of load when modifying an insoluble drug by the polyethylene glycol. The preparation method of the dendritic polyethylene glycol derivative provided by the disclosure has mild reaction conditions, is green and environmentally friendly, is low in cost, and is easy to implement industrialization.